To evaluate the efficacy and safety of subcutaneous and intravenous abatacept.
Phase of Trial: Phase III
Latest Information Update: 14 Sep 2018
Price : $35 *
At a glance
- Drugs Abatacept (Primary) ; Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 08 Sep 2018 Status changed from active, no longer recruiting to completed.
- 22 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 27 Mar 2014 New trial record